Barely Significant
← all excerpts

Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.

Nephrol Dial Transplant · 2017 · PMC5837351 · PMID 27190355

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

did not reach statistical significanceP<0.0001actually significant
After 12 months, uMCP1 excretion was lower in the tolvaptan than in the placebo group, but did not reach statistical significance until 24 (13.8 ± 3.4%, P<0.0001) and 36 months (14.4 ± 3.7%, P<0.0001).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.